Invited Commentary
Commentary on "Predictor of 90-Day Readmission Rate for Hepatic Encephalopathy"
Abstract
Hepatic encephalopathy (HE) is associated with serious mortality and morbidity, including recurrent hospitalization. Readmission rates have always been a serious topic because they have a direct impact on patients’ well-being and the quality of medical management. They are assuming increasing importance in today’s healthcare environment, where statistical tools (eg, Crimson, Truven) are being used to evaluate physicians on their readmission rates. Furthermore, section 3025 of the Patient Protection and Affordable Care Act (PL 111-148) requires the Centers for Medicare & Medicaid Services to reduce payments to hospitals with excess readmissions within 30 days of discharge. Comorbid conditions that increase risk for rehospitalization in HE are not well studied.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.